Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.
01 1Egis Pharmaceuticals PLC
02 1Lee Fine Chem
03 32care4
04 1Alembic Pharmaceuticals Limited
05 17Novartis Pharmaceuticals Corporation
06 1Novartis South Africa (Pty) Ltd
01 1FCT
02 11Film Coated Tablet
03 1Film-Coated Tablet
04 1TABLET
05 1TABLET; ORAL
06 2TABLET;ORAL
07 2Tablet
08 5Blank
01 1Allowed
02 1Approved
03 3Authorized
04 6Marketed
05 1Originator
06 2Prescription
07 2RX
08 8Blank
01 2KISQALI
02 1KISQALI FEMARA CO-PACK (COPACKAGED)
03 1KRYXANA 200MG
04 17Kisqali
05 1RIBOCICLIB
06 2Ribociclib
01 5Australia
02 1Canada
03 1Estonia
04 1Hungary
05 1India
06 6Norway
07 1South Africa
08 3Spain
09 1Sweden
10 1Switzerland
11 3USA
Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.
Regulatory Info :
Registration Country : Hungary
Brand Name : Ribociclib
Dosage Form : Tablet
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Hungary
Lee Fine Chem: Advancing Innovation and Quality in Intermediates, APIs, and Dosage Forms for Superior Pharmaceutical Solutions.
Regulatory Info :
Registration Country : India
Brand Name : Ribociclib
Dosage Form : Tablet
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info : Marketed
Registration Country : Norway
Brand Name : Kisqali
Dosage Form : Film Coated Tablet
Dosage Strength : 200mg
Packaging :
Approval Date :
Application Number :
Regulatory Info : Marketed
Registration Country : Norway
Regulatory Info : Marketed
Registration Country : Norway
Brand Name : Kisqali
Dosage Form : Film Coated Tablet
Dosage Strength : 200mg
Packaging :
Approval Date :
Application Number :
Regulatory Info : Marketed
Registration Country : Norway
Regulatory Info : Marketed
Registration Country : Norway
Brand Name : Kisqali
Dosage Form : Film Coated Tablet
Dosage Strength : 200mg
Packaging :
Approval Date :
Application Number :
Regulatory Info : Marketed
Registration Country : Norway
Regulatory Info :
Registration Country : USA
Brand Name : RIBOCICLIB
Dosage Form : TABLET; ORAL
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number : 215677
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : KISQALI
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 200MG BASE
Packaging :
Approval Date : 2017-03-13
Application Number : 209092
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
LETROZOLE; RIBOCICLIB SUCCINATE
Brand Name : KISQALI FEMARA CO-PACK (COPACKAGED)
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG;EQ 200MG BASE
Packaging :
Approval Date : 2017-05-04
Application Number : 209935
Regulatory Info : RX
Registration Country : USA
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Kisqali
Dosage Form : Film Coated Tablet
Dosage Strength : 200mg
Packaging :
Approval Date : 24/10/2017
Application Number : 66377
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Kisqali
Dosage Form : Film Coated Tablet
Dosage Strength : 200mg
Packaging :
Approval Date : 22/08/2017
Application Number : 20160906000055
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : Prescription
Registration Country : Canada
RIBOCICLIB (RIBOCICLIB SUCCINATE)
Brand Name : KISQALI
Dosage Form : TABLET
Dosage Strength : 200MG
Packaging : 21/42/63
Approval Date :
Application Number : 2473569
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info :
Registration Country : Australia
Brand Name : Kisqali
Dosage Form :
Dosage Strength :
Packaging : 21
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : Kisqali
Dosage Form :
Dosage Strength :
Packaging : 63
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : Kisqali
Dosage Form :
Dosage Strength :
Packaging : 42
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : Kisqali
Dosage Form :
Dosage Strength :
Packaging : 21
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : Kisqali
Dosage Form :
Dosage Strength :
Packaging : 42
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info : Marketed
Registration Country : Norway
Brand Name : Kisqali
Dosage Form : Film Coated Tablet
Dosage Strength : 200mg
Packaging :
Approval Date :
Application Number :
Regulatory Info : Marketed
Registration Country : Norway
Regulatory Info : Marketed
Registration Country : Norway
Brand Name : Kisqali
Dosage Form : Film Coated Tablet
Dosage Strength : 200mg
Packaging :
Approval Date :
Application Number :
Regulatory Info : Marketed
Registration Country : Norway
Regulatory Info : Marketed
Registration Country : Norway
Brand Name : Kisqali
Dosage Form : Film Coated Tablet
Dosage Strength : 200mg
Packaging :
Approval Date :
Application Number :
Regulatory Info : Marketed
Registration Country : Norway
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : KRYXANA 200MG
Dosage Form : FCT
Dosage Strength : 200mg
Packaging : 21X1mg
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
